|
The document outlines a pharmacokinetic study protocol by 3M to assess the oral absorption, clearance, and biological persistence of Perfluorooctane Sulfonamide (PFOSA) in rats, aiming to investigate its potential conversion to PFOS and improve risk characterization.
|
— |
AR226-0664
|
QM2gDO4bmxob5gao5GN7mVnz6 |
333 |